Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes
NCT04051502Phase 1Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of indocyanine green in ovarian cancer and adnexal mass (4 arms), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Number and location of ovarian sentinel lymph nodes visually identified at 1 year. Started Aug 2019; status: completed.
02
Drugs
indocyanine green
03
Conditions
ovarian canceradnexal mass
Beyond the preview
Go deeper on NCT04051502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04051502.